12
DSAEK Outcomes in Normal and Abnormal, High-Risk Eyes at an University Practice Hugo Y. Hsu and Sean L. Edelstein The authors have no financial interest in the subject matter of this poster study was supported in part by an unrestricted grant from Research to Prevent Blindness (RPB), Inc.

DSAEK Outcomes in Normal and Abnormal, High-Risk Eyes at an University Practice

  • Upload
    vanig

  • View
    41

  • Download
    1

Embed Size (px)

DESCRIPTION

DSAEK Outcomes in Normal and Abnormal, High-Risk Eyes at an University Practice. Hugo Y. Hsu and Sean L. Edelstein The authors have no financial interest in the subject matter of this poster. - PowerPoint PPT Presentation

Citation preview

Page 1: DSAEK Outcomes in Normal and Abnormal, High-Risk Eyes at an University Practice

DSAEK Outcomes in Normal and Abnormal, High-Risk Eyes at an

University PracticeHugo Y. Hsu and Sean L. EdelsteinThe authors have no financial interest in the subject

matter of this poster

This study was supported in part by an unrestricted grant from Research to Prevent Blindness (RPB), Inc.

Page 2: DSAEK Outcomes in Normal and Abnormal, High-Risk Eyes at an University Practice

Background

• An important step in the successful attachment of a donor lenticule for endothelial keratoplasty in its currently popular form (Descemet-stripping--DSAEK) is the ability to fill the anterior chamber completely with an air bubble after the introduction of the donor lenticule.

• Many post-surgical anterior segment changes (e.g. aphakia) makes a successful air-fill difficult if not impossible, and this potentially leads more tissue handling and damage.

• Several investigators have published series on the outcomes and results of DSAEK in relatively “normal” eyes, but few have tackled the outcomes (surgical and functional) in the “high-risk” eyes.

Page 3: DSAEK Outcomes in Normal and Abnormal, High-Risk Eyes at an University Practice

Purpose

• To compare the outcomes of our initial experience with DSAEK involving “normal” eyes such as isolated Fuch’s dystrophy or primary post cataract-extraction cornea edema and abnormal, high-risk eyes such as those having undergone multiple surgeries and/or have abnormalities of the anterior segment with compromise of the iris-lens diaphragm.

Page 4: DSAEK Outcomes in Normal and Abnormal, High-Risk Eyes at an University Practice

Methods

• The initial series of DSAEK patient at our inner-city, university-based, referral practice from April 2007 to December 2008 were retrospectively reviewed.*

• Patients were separated into “normal” and high-risk groups (defined next).

• Lenticule detachment, visual recovery, endothelial cell counts, and complication rates were compared between the two groups.

• Chi-square, and t-test statistics were employed to determine the difference between the two groups.

* All surgeries were performed by the senior author (HYH) using the technique described by Terry et al.

Page 5: DSAEK Outcomes in Normal and Abnormal, High-Risk Eyes at an University Practice

“normal” vs. “high-risk” eyes

• Normal

• Fuch’s dystrophy• Post cataract-

surgery cornea edema

• High-risk

• Aphakia• Post vitrectomy eyes• Partial or complete

loss of iris• Glaucoma tubes or

trabs• Anterior-chamber

IOL’s• Iris-cornea adhesion

or anterior chamber fibrosis

Page 6: DSAEK Outcomes in Normal and Abnormal, High-Risk Eyes at an University Practice

Example of a “normal” eye

• 77 yo woman with Fuch’s dystrophy and cataract who is status-post a traditional triple procedure with penetrating keratoplasty in the left eye 2 year prior wished to have surgical intervention to improve the failing vision in her right eye.

• Patient underwent a “new” triple procedure with cataract extraction via phacoemulsification, capsule-placement of an intra-ocular lens, and DSAEK.

Page 7: DSAEK Outcomes in Normal and Abnormal, High-Risk Eyes at an University Practice

Example of a “high-risk” eye

• 73 yo male blind in the left eye due to glaucoma developed cornea edema in the right eye after a history cataract extraction with a sulcus-placed IOL, anterior vitrectomy, failed trabeculectomy, glaucoma tube implantation, and multiple trans-scleral cyclophotocoagulation treatments.

• Patient underwent DSAEK. Intra-operatively, it was discovered that the patient’s IOL was unstable in the sulcus space. He had broad areas of iris-corneal adhesions, and he had poor tissue integrity.

Page 8: DSAEK Outcomes in Normal and Abnormal, High-Risk Eyes at an University Practice

Results: Patient Characteristics

N (eyes) Age % Female

Normal 12 65 33%

High-risk 19 62 63%

Page 9: DSAEK Outcomes in Normal and Abnormal, High-Risk Eyes at an University Practice

Results: Endothelial Cell Density

Donor age Initial 0.5 year 1.0 year 1.5 year

Normal 47.25 2824N=12

1266N=7

1306N=7

902N=7

High-risk 50.67 3044N=18

1666N=6

1512N=5

1370N=4

P-value 0.48 0.025 0.25 0.36 <0.01

Page 10: DSAEK Outcomes in Normal and Abnormal, High-Risk Eyes at an University Practice

Results: Visual Acuity

Initial 1 year 1.5 year

Normal0.72

(20/105)N=12

0.35(20/45)

N=12

0.37(20/47)

N=11

High-risk1.21

(20/324)N=18

0.27(20/37)

N=8

0.24(20/35)

N=6

P-value 0.04 0.39 0.35

Page 11: DSAEK Outcomes in Normal and Abnormal, High-Risk Eyes at an University Practice

Results: Adverse Events & Complications

• Normal (n=12)

• Non-attachment (1; 8%)

• Detachment week one (1; 8%)

• Late increase IOP (3)

• Cataract formation (1)

• High-risk (n=19)

• Non-attachment (5; 26%)

• Detachment week one (2; 10.5%)

• Failure to reattach (3)

• Primary failure (3)

• Dropped lenticule (1)

• Rejection--resolved (1)

• Rejection--graft failure (1)

• Day-one pressure spike (1)*

• Rupture globe (1)*Air occlusion of trab ostomy

Page 12: DSAEK Outcomes in Normal and Abnormal, High-Risk Eyes at an University Practice

Conclusion

• High-risk eyes have high complication rates.• However, collectively, the visual recovery and

endothelial cell survival in high-risk eyes compare favorably against normal eyes.

• Therefore, despite the increased challenge, DSAEK should, in general, be offered to patients with higher risk profiles.

• Techniques to further minimize complications need to be developed and evaluated.